In vitro sensitivity of immature human mast cells to chemotherapeutic agents

J. H. Butterfield, D. A. Weiler

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Cells from the human immature mast cell line, HMC-1, were tested for their sensitivity to 11 chemotherapeutic agents by changes in viability and incorporation of tritiated thymidine ([3H]-thymidine) after 72 h of in vitro drug exposure. Doxorubicin hydrochloride and cytosine arabinoside were the most active agents against HMC-1 cells at the concentrations tested. Doxorubicin hydrochloride inhibited the incorporation of [3H]-thymidine and decreased the viability of HMC-1 cells by >90% at a concentration of 0.06 μg/ml. Cytosine arabinoside inhibited the incorporation of [3H]-thymidine and decreased the viability by >95% at a concentration of 0.1 μg/ml. A clone of HMC-1 cells, A4, with an enhanced percentage (70-80%) of metachromatically staining cells was equally sensitive to these two agents; however, A4 cells were more sensitive to vinblastine sulfate and less sensitive to methylprednisolone than was the parent cell line. Both HMC-1 cells and A4 cells showed approximately equal sensitivity to etoposide and to mitomycin. These results show that human mast cells are susceptible in vitro to a number of commonly used chemotherapeutic drugs.

Original languageEnglish (US)
Pages (from-to)297-300
Number of pages4
JournalInternational Archives of Allergy and Applied Immunology
Volume89
Issue number2-3
StatePublished - 1989

Fingerprint

Mast Cells
Thymidine
Cytarabine
Doxorubicin
Cell Line
Vinblastine
In Vitro Techniques
Methylprednisolone
Mitomycin
Etoposide
Pharmaceutical Preparations
Clone Cells
Staining and Labeling

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

In vitro sensitivity of immature human mast cells to chemotherapeutic agents. / Butterfield, J. H.; Weiler, D. A.

In: International Archives of Allergy and Applied Immunology, Vol. 89, No. 2-3, 1989, p. 297-300.

Research output: Contribution to journalArticle

@article{d971049d4a8b40eda7b7c563a4c7a860,
title = "In vitro sensitivity of immature human mast cells to chemotherapeutic agents",
abstract = "Cells from the human immature mast cell line, HMC-1, were tested for their sensitivity to 11 chemotherapeutic agents by changes in viability and incorporation of tritiated thymidine ([3H]-thymidine) after 72 h of in vitro drug exposure. Doxorubicin hydrochloride and cytosine arabinoside were the most active agents against HMC-1 cells at the concentrations tested. Doxorubicin hydrochloride inhibited the incorporation of [3H]-thymidine and decreased the viability of HMC-1 cells by >90{\%} at a concentration of 0.06 μg/ml. Cytosine arabinoside inhibited the incorporation of [3H]-thymidine and decreased the viability by >95{\%} at a concentration of 0.1 μg/ml. A clone of HMC-1 cells, A4, with an enhanced percentage (70-80{\%}) of metachromatically staining cells was equally sensitive to these two agents; however, A4 cells were more sensitive to vinblastine sulfate and less sensitive to methylprednisolone than was the parent cell line. Both HMC-1 cells and A4 cells showed approximately equal sensitivity to etoposide and to mitomycin. These results show that human mast cells are susceptible in vitro to a number of commonly used chemotherapeutic drugs.",
author = "Butterfield, {J. H.} and Weiler, {D. A.}",
year = "1989",
language = "English (US)",
volume = "89",
pages = "297--300",
journal = "International Archives of Allergy and Immunology",
issn = "1018-2438",
publisher = "S. Karger AG",
number = "2-3",

}

TY - JOUR

T1 - In vitro sensitivity of immature human mast cells to chemotherapeutic agents

AU - Butterfield, J. H.

AU - Weiler, D. A.

PY - 1989

Y1 - 1989

N2 - Cells from the human immature mast cell line, HMC-1, were tested for their sensitivity to 11 chemotherapeutic agents by changes in viability and incorporation of tritiated thymidine ([3H]-thymidine) after 72 h of in vitro drug exposure. Doxorubicin hydrochloride and cytosine arabinoside were the most active agents against HMC-1 cells at the concentrations tested. Doxorubicin hydrochloride inhibited the incorporation of [3H]-thymidine and decreased the viability of HMC-1 cells by >90% at a concentration of 0.06 μg/ml. Cytosine arabinoside inhibited the incorporation of [3H]-thymidine and decreased the viability by >95% at a concentration of 0.1 μg/ml. A clone of HMC-1 cells, A4, with an enhanced percentage (70-80%) of metachromatically staining cells was equally sensitive to these two agents; however, A4 cells were more sensitive to vinblastine sulfate and less sensitive to methylprednisolone than was the parent cell line. Both HMC-1 cells and A4 cells showed approximately equal sensitivity to etoposide and to mitomycin. These results show that human mast cells are susceptible in vitro to a number of commonly used chemotherapeutic drugs.

AB - Cells from the human immature mast cell line, HMC-1, were tested for their sensitivity to 11 chemotherapeutic agents by changes in viability and incorporation of tritiated thymidine ([3H]-thymidine) after 72 h of in vitro drug exposure. Doxorubicin hydrochloride and cytosine arabinoside were the most active agents against HMC-1 cells at the concentrations tested. Doxorubicin hydrochloride inhibited the incorporation of [3H]-thymidine and decreased the viability of HMC-1 cells by >90% at a concentration of 0.06 μg/ml. Cytosine arabinoside inhibited the incorporation of [3H]-thymidine and decreased the viability by >95% at a concentration of 0.1 μg/ml. A clone of HMC-1 cells, A4, with an enhanced percentage (70-80%) of metachromatically staining cells was equally sensitive to these two agents; however, A4 cells were more sensitive to vinblastine sulfate and less sensitive to methylprednisolone than was the parent cell line. Both HMC-1 cells and A4 cells showed approximately equal sensitivity to etoposide and to mitomycin. These results show that human mast cells are susceptible in vitro to a number of commonly used chemotherapeutic drugs.

UR - http://www.scopus.com/inward/record.url?scp=0024400189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024400189&partnerID=8YFLogxK

M3 - Article

C2 - 2759719

AN - SCOPUS:0024400189

VL - 89

SP - 297

EP - 300

JO - International Archives of Allergy and Immunology

JF - International Archives of Allergy and Immunology

SN - 1018-2438

IS - 2-3

ER -